What Is Tumor-Infiltrating Lymphocyte (TIL) Therapy? Answered by Allison Betof Warner, MD
In this video story from Stanford Department of Medicine's 2024 Annual Report on "New Frontiers," Mark and Mary Stevens Scholar at Stanford, Allison Betof Warner, MD, explains how she’s bringing new hope to cancer treatments with TIL therapy.
▶︎
5 Minute Check In: Tumor-Infiltrating Lymphocyte Therapy in Advanced Melanoma
▶︎
What is TIL therapy for cancer and how does it work? | Ohio State Medical Center
▶︎
Dr. Eric Tran's presentation on TILs and cell therapy for cholangiocarcinoma
▶︎
TIL Therapy for Advanced Melanoma
▶︎
TIL Therapy Revolution: 96% Survival & 67% Response in Melanoma - Dr. Allison Betof Warner
▶︎
CAR T Cells: Beating Cancer with the Immune System
▶︎
2025 Mayo Clinic Patient & Caregiver Symposia: TIL Therapy for Melanoma
▶︎
Tumor Infiltrating Lymphocyte (TIL) Cell Therapy in Melanoma
▶︎
The WORST Food That Feeds Cancer Cells & New Way To STARVE Disease | Dr. Thomas Seyfried
▶︎
Strengthening T Cell Therapy for Solid Tumor Cancers with Jaehyuk Choi, MD, PhD
▶︎
The FDA Approval of TIL Therapy and What it Means for Advanced Melanoma
▶︎
Understanding TIL (Tumour-infiltrating lymphocyte) Therapy
▶︎
Cell Therapy in the Treatment of Solid Tumors
▶︎
Tumor-Infiltrating Lymphocyte Therapy: Ask Geoffrey Gibney
▶︎
Billionaire's WARNING: I'm SELLING. The Crash Is Already Here!
▶︎
Immunotherapy and the side effects
▶︎
Crystal Mackall on CAR-T Breakthroughs, Beating Childhood Cancer, and the Future of Cell Therapy
▶︎
TIL and Adoptive Therapy - Mark B Faries MD
▶︎
This Isn't Experimental: Vitamin K2 Kills Cancer — But Only at This Dose | Cancer Drug Designer
▶︎